ACT CAPITAL MANAGEMENT, LLC
Q4 2025 13F Holdings
- Locationwayne, PA
- Num holdings
58
- Value ($000)
$123,670
- Date Filed02/17/2026
- Form type13F-HR
- CIK0001442273
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
KRYSTAL BIOTECH INC | COM | 501147102 | $14.92M | 12 % | 60,500 | ||
CHEVRON CORP NEW | COM | 166764100 | $11.96M | 10 % | 78,500 | ||
EXXON MOBIL CORP | COM | 30231G102 | $9.93M | 8 % | 82,500 | ||
ABIVAX | SPONSORED ADS | 00370M103 | $8.62M | 7 % | 63,900 | ||
TG THERAPEUTICS INC | COM | 88322Q108 | $8.02M | 7 % | 268,875 | ||
VIKING THERAPEUTICS INC | COM | 92686J106 | $7.25M | 6 % | 206,100 | ||
CELCUITY INC | COM | 15102K100 | $6.33M | 5 % | 63,415 | ||
AMAZON.COM INC | COM | 023135106 | $5.68M | 5 % | 24,600 | ||
NUVATION BIO INC | COM CL A | 67080N101 | $5.47M | 4 % | 610,500 | ||
ARROWHEAD PHARMACEUTICALS INC | COM | 04280A100 | $4.98M | 4 % | 75,000 |
Rows Per Page
10
- 5
- 10
- 20
- 30
- 50
- 100